Clinical Study of Recombinant Novel Coronavirus Vaccine

NCT04466085 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

900

Enrollment

INDUSTRY

Sponsor class

Conditions

Coronavirus

Interventions

BIOLOGICAL: Recombinant new coronavirus vaccine (CHO cell) low-dose group
BIOLOGICAL: Recombinant new coronavirus vaccine (CHO cells) high-dose group
BIOLOGICAL: Recombinant new coronavirus vaccine (CHO cells) placebo group

Sponsor

Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.